Endodontic pain. Disorder of teeth and supporting structures, unspecified
Conditions
Interventions
Intervention 1: Gelofena as capsule 400 mg, oral, one dose 2 houres before starting the treatment. Intervention 2: placebo as capsule, oral one dose 2 houres before starting the treatment. Interventio
Treatment - Drugs
Placebo
Gelofena as capsule 400 mg, oral, one dose 2 houres before starting the treatment
placebo as capsule, oral one dose 2 houres before starting the treatment
Celecoxib as capsule 200mg, per oral one dose 2 houres before starting the treatment
Sponsors
Vice chancellor for research, Shiraz University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Inclusion criteria: age between 18 to 65; and having vital premolars of mandible or maxilla without any pre apical lesion Exclusion criteria: pregnancy; allergy to sulfonamide and NSAIDs; history of asthma related to nasal polyp; history of chronic using of analgesics; alcohol using; uncontrollable high blood pressure; diabetes mellitus; systemic disease and not using analgesic medicine 12 hours before study
Exclusion criteria
Exclusion criteria:
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Pain. Timepoint: 4, 8, 12, 24 and 48 hours after intervention. Method of measurement: VAS scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactShaghayegh Nooribayat
Dental student of Research Committee, Dental Faculty, Babol University of Medical Sciences
Outcome results
None listed